M2 TAMs increase angiogenesis by upregulating angiogenesis-associated genes such as VEGF, PDGF, and PGE2, or via molecules CXCL12, IL-1β, IL-8 and Sema4d, leading to tumor progression (98, 102). The gene discussed is IL1B; the disease is neoplasm.